Login

Novavax Plant Could Become Second Major Quebec Vaccine Facility To Close This Year

Medicago Announced Closure of Quebec City Facility Last Month
Canada's federal government recently spent $126 million on the Novavax facility at 6100 Royalmount Ave. in Montreal. (CoStar)
Canada's federal government recently spent $126 million on the Novavax facility at 6100 Royalmount Ave. in Montreal. (CoStar)

An announcement by Marilyn-based vaccine maker Novavax that it faces an uncertain future has led to concerns that a second newly built, government-subsidized vaccine facility could go vacant in Quebec following the closure of the Medicago vaccine facility in Quebec City in early February.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE